Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Dysfunctional Uterine Bleeding Clinical Trials

A listing of Dysfunctional Uterine Bleeding medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (6) clinical trials

If you have been living with heavy periods due to uterine fibroids, participating in a research study may be an option. The Asteroid Studies are research studies evaluating the safety and effectiveness of an investigational oral medication for uterine fibroids. 

Phase N/A

Surgical Success After Laparoscopic vs Abdominal Hysterectomy

The overall hypothesis is that neither mode of hysterectomy will be consistently superior to the other with respect to each of the three domains of complications, cost, and patient-centered outcomes. The overall goal of the study is to determine which clinically relevant factors may impact the choice of LH compared ...

Phase

CavatermTM vs TCRE in Women With DUB

Study success will be defined as reduction of uterine bleeding evaluated by number of patients obtaining amenorrhea, hypomenorrhea or eumenorrhea quantified by PBLAC<75.

Phase

Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation

Menorrhagia is frequent and occur in 11 to 13 % of the general population. It accounts for 20% of the gynecological consultations and tends to increase with age. It can be the first symptom of a mild uterine disease or cancer (cervical or endometrial), especially if the patient is older. ...

Phase N/A

Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users

The investigators will perform a 2 phase trial for treatment of women experiencing frequent or prolonged bleeding while using the ENG contraceptive implant. The first phase will consist of a randomized, controlled, double blind placebo-controlled clinical trial over a 90-day reference period and the second phase will allow both study ...

Phase

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

New users of the LNG IUS will be eligible. Subjects will be randomized to receive tamoxifen 10 mg BID for 7 days or placebo. Study drug will be started 3 weeks after placement of the IUS. Subjects will maintain a record of daily bleeding and spotting using an electronic text ...

Phase